Close

Ratings by Cowen (Tyler Van Buren)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/6/2023 BridgeBio Pharma BBIO New Coverage Outperform
(N/A)
10.86
(11.42)
5.16% Details
1/30/2023 Regeneron Pharma REGN Upgrade Outperform
(Market Perform)
742.83
(794.81)
7% Details
1/25/2023 Deciphera DCPH Maintain Outperform
(N/A)
 
 
  Details
1/25/2023 Moderna MRNA Maintain Market Perform
(N/A)
 
 
  Details
1/6/2023 Fate Therapeutics FATE Downgrade Market Perform
(Outperform)
11.00
(6.78)
-38.36% Details
12/22/2022 Rocket Pharmaceuticals RCKT Maintain Outperform
(N/A)
 
 
  Details
12/9/2022 Deciphera DCPH Maintain Outperform
(N/A)
 
 
  Details
11/9/2022 Immunocore Holdings IMCR Maintain Outperform
(N/A)
 
 
  Details
11/8/2022 Gilead Sciences GILD Maintain Outperform
(N/A)
 
 
  Details
11/3/2022 Moderna MRNA Maintain Outperform
(N/A)
 
 
  Details
10/20/2022 Regeneron Pharma REGN Maintain Market Perform
(N/A)
 
 
  Details
10/20/2022 Moderna MRNA Maintain Outperform
(N/A)
 
 
  Details
8/29/2022 Deciphera DCPH New Coverage Outperform
(N/A)
14.85
(16.90)
13.8% Details
8/8/2022 Immunocore Holdings IMCR New Coverage Outperform
(N/A)
54.40
(61.88)
13.75% Details
8/3/2022 Regeneron Pharma REGN Maintain Market Perform
(N/A)
 
 
  Details
7/20/2022 Regeneron Pharma REGN Maintain Market Perform
(N/A)
 
 
  Details
7/12/2022 Zentalis Pharmaceuticals ZNTL New Coverage Outperform
(N/A)
27.16
(22.59)
-16.83% Details
6/22/2022 Moderna MRNA Maintain Market Perform
(N/A)
 
 
  Details
6/8/2022 Mirati Therapeutics MRTX Maintain Outperform
(Outperform)
 
 
  Details
6/6/2022 Turning Point Therapeutics Inc. TPTX Downgrade Market Perform
(Outperform)
74.59
(76.01)
1.9% Details
5/4/2022 Regeneron Pharma REGN Maintain Market Perform
(N/A)
 
 
  Details
4/20/2022 Regeneron Pharma REGN Maintain Market Perform
(N/A)
 
 
  Details
4/18/2022 Gilead Sciences GILD Maintain Outperform
(Outperform)
 
 
  Details
4/6/2022 Iovanace Biotherapeutics IOVA Maintain Outperform
(Outperform)
 
 
  Details
3/23/2022 Moderna MRNA Maintain Outperform
(Outperform)
 
 
  Details
3/7/2022 Gilead Sciences GILD Maintain Outperform
(Outperform)
 
 
  Details
3/4/2022 Tyra Biosciences TYRA Maintain Outperform
(Outperform)
 
 
  Details
3/1/2022 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(Outperform)
 
 
  Details
2/28/2022 Arvinas Inc. ARVN Maintain Outperform
(Outperform)
 
 
  Details
2/24/2022 Allogene ALLO Maintain Outperform
(Outperform)
 
 
  Details
2/17/2022 Arvinas Inc. ARVN Maintain Outperform
(Outperform)
 
 
  Details
2/16/2022 Mirati Therapeutics MRTX Maintain Outperform
(Outperform)
 
 
  Details
2/4/2022 Regeneron Pharma REGN Maintain Market Perform
(N/A)
 
 
  Details
1/31/2022 Moderna MRNA Maintain Market Perform
(Market Perform)
 
 
  Details
1/27/2022 Moderna MRNA Maintain Market Perform
(N/A)
 
 
  Details
12/13/2021 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
12/13/2021 Allogene ALLO Maintain Outperform
(N/A)
 
 
  Details
12/7/2021 Olema Pharmaceuticals OLMA New Coverage Outperform
(N/A)
10.47
(4.71)
-55.01% Details
12/7/2021 Iovanace Biotherapeutics IOVA New Coverage Outperform
(N/A)
16.55
(8.39)
-49.31% Details
12/7/2021 Regeneron Pharma REGN New Coverage Market Perform
(N/A)
635.16
(794.81)
25.14% Details
12/7/2021 CRISPR Therapeutics CRSP New Coverage Market Perform
(N/A)
70.09
(55.62)
-20.64% Details
12/7/2021 Fate Therapeutics FATE New Coverage Outperform
(N/A)
48.00
(6.78)
-85.88% Details
12/7/2021 Moderna MRNA New Coverage Market Perform
(N/A)
306.72
(173.38)
-43.47% Details
12/7/2021 Arvinas Inc. ARVN New Coverage Outperform
(N/A)
74.44
(35.09)
-52.86% Details
10/20/2021 Kronos Bio Inc. KRON New Coverage Outperform
(N/A)
16.49
(2.34)
-85.81% Details
10/20/2021 Rocket Pharmaceuticals RCKT New Coverage Outperform
(N/A)
27.59
(20.44)
-25.92% Details
10/20/2021 Gilead Sciences GILD New Coverage Outperform
(N/A)
65.90
(86.40)
31.11% Details
10/20/2021 Allogene ALLO New Coverage Outperform
(N/A)
15.73
(7.75)
-50.73% Details
10/20/2021 Allogene ALLO New Coverage Outperform
(N/A)
15.73
(7.75)
-50.73% Details
10/11/2021 Tyra Biosciences TYRA New Coverage Outperform
(N/A)
16.26
(13.11)
-19.37% Details